Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
Launched by RENJI HOSPITAL · Mar 17, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how brain activity, measured by a technique called EEG (electroencephalogram), can help doctors understand the chances of recovery for patients in a coma due to severe brain injuries. The goal is to find a reliable and easy way to assess levels of consciousness in these patients over time. By looking at patterns in the brain’s electrical activity, researchers hope to gain valuable insights into how and when a patient might regain awareness.
To participate in this study, individuals must be at least 18 years old and have been in a coma for more than 28 days because of a closed traumatic brain injury. They need to have a legal representative who can provide consent for them to join. However, patients with unstable vital signs, a history of severe mental illnesses, uncontrolled epilepsy, or who are pregnant cannot participate. The study is still in the planning phase and has not yet started recruiting participants, but it holds the promise of improving how doctors can predict recovery outcomes for patients in similar situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Coma over 28 days due to closed traumatic brain injury
- • Age above 18 years old
- • Consented by legal representative
- Exclusion Criteria:
- • Unstable vital signs
- • History of mental disorder or neurodegenerative diseases
- • Uncontrolled epilepsy
- • Unable to record scalp EEG
- • Pregnancy
About Renji Hospital
Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Changsha, Hunan, China
Beijing, Beijing, China
Shanghai, Shanghai, China
Hefei, Anhui, China
Nanjing, Jiangsu, China
Patients applied
Trial Officials
Junfeng Feng, Dr.
Study Director
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Guoyi Gao, Dr.
Study Director
Beijing Tiantan Hospital
Jinfang Liu, Dr.
Study Director
Xiangya Hospital of Central South University
Chiyuan Ma, Dr.
Study Director
The General Hospital of Eastern Theater Command
Yongming Zhang, Dr.
Study Director
Anhui No.2 Provincial People's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported